mani
adenoviru
field
strain
exhibit
serolog
relationship
two
differ
prototyp
differ
found
sn
hi
exampl
intermedi
strain
h
hemagglutinin
doubli
neutraliz
strain
strain
crossreact
hi
two
differ
type
variant
character
dna
restrict
analysi
use
least
seven
endonucleas
dna
serolog
ident
strain
show
slight
variat
comparison
variant
serolog
relat
prototyp
result
moder
dna
relationship
comigr
fragment
except
possibl
serolog
variant
origin
recombin
two
prototypelik
strain
respect
data
present
intermedi
strain
aim
investig
answer
three
question
preval
delta
hepat
southwestgermani
preval
inappar
hdv
infect
clinic
cours
delta
hepat
differ
hepat
b
materi
method
six
hundr
fiftythre
hbsag
pa
one
hundr
fiftytwo
hbsag
neglantihbclhiv
po
sera
reinvestig
antidelta
igg
igm
deltak
deltaigmk
sorin
data
clinic
cours
taken
patient
histori
result
discuss
preval
delta
hepat
hbsagpo
patient
preval
inappar
hdv
infect
hbsag
neglantihbc
po
drug
addict
ident
preval
hdv
infect
appar
unappar
hbv
infect
conclud
everi
hdv
infect
correl
clinic
hepat
antidelta
igm
detect
hbsagantidelta
po
sera
well
antideltaantihbc
po
sera
hbsag
neg
drug
addict
autoantibodi
detect
patient
case
liver
biopsi
done
demonstr
antidelta
igm
autoantibodi
thu
detect
antidelta
igm
autoantibodi
indic
chronic
h
contain
human
endogen
retrovir
element
relat
simian
sarcoma
viru
ssv
associ
viru
ssa
v
sequenc
analysi
comparison
correspond
ssvlssav
sequenc
genom
organ
element
determin
gagsnrspolltr
snr
repres
region
bp
consist
nonretrovira
sequenc
probe
contain
complet
element
use
screen
two
human
cdna
librari
lowsting
condit
clone
isol
yield
strong
hybridis
signal
probe
hybridis
clone
differ
fragment
genom
reveal
clone
contain
snr
relat
sequenc
five
isol
clone
sequenc
compar
one
contain
homolog
l
tr
outer
four
clone
sequenc
ident
snr
nucleotid
level
deduc
amino
acid
sequenc
four
snr
clone
homolog
snr
none
sequenc
repres
contigu
open
read
frame
result
indic
snrss
probabl
protein
encod
function
hybridis
human
genom
dna
show
snr
belong
multicopi
famili
relat
sequenc
human
immunodefici
virus
human
lymphotrop
virus
human
spumaretroviru
hsrv
constitut
natur
occur
human
retrovirus
molecular
clone
sequenc
hsrv
reveal
four
open
read
frame
orf
addit
gag
pol
env
three
addit
orf
bel
locat
berween
env
gene
one
addit
orf
sl
loact
central
region
genom
function
analysi
bel
gene
requir
infecti
molecular
clone
hsrv
avail
far
construct
clone
phsrv
biolog
activ
clone
confirm
varieti
criteria
induct
characterist
cpe
suscept
cell
infect
cellfre
supernat
cultur
transfect
phsrv
indirect
immunofluoresc
radioimmunoprecipit
viral
protein
electron
microscopi
furthermor
shown
phsrv
abl
transactiv
hsrvltr
glycoprotein
iv
bovin
herpesviru
bhvl
one
major
immunogen
glycoprotein
viral
envelop
involv
absorpt
andor
penetr
viru
esenti
product
infecti
viru
delet
viral
genom
contrast
analog
protein
herp
simplex
viru
gd
pseudorabi
viru
giv
show
size
heterogen
among
differ
strain
indic
least
one
part
polypeptid
backbon
aminoacid
composit
variabl
comparison
nucleotid
sequenc
four
strain
reveal
size
heterogen
strain
due
differ
repetit
bp
sequenc
locat
upstream
sequenc
code
membran
span
domain
giv
current
test
possibl
introduc
heterolog
sequenc
part
giv
analys
whether
giv
contain
antigen
epitop
differ
virus
without
affect
function
activ
giv
molluscum
contagiosum
viru
mcv
member
famili
poxvirida
induc
epiderm
prolifer
man
genom
mcv
type
mcvl
kbp
character
physic
map
use
defin
gene
librari
viral
genom
dnadna
hybrid
physic
map
viral
genom
construct
restrict
endonucleas
bamhi
clai
ecori
hindiii
detail
hybrid
experi
reveal
presenc
repetit
dna
sequenc
locat
within
termin
region
viral
genom
e
g
bamhi
dna
fragment
b
kbp
mu
e
kbp
mu
fine
map
particular
region
indic
repetit
dna
sequenc
locat
within
hindiii
dna
fragment
jl
kbp
mu
k
kbp
mu
pi
kbp
mu
kbp
mu
nucleotid
sequenc
analysi
carri
found
hindiii
fragment
jl
k
contain
invert
repeat
bp
bp
respect
homolog
repetit
dna
element
found
analysi
code
capac
determin
dna
sequenc
reveal
presenc
open
read
frame
hindiii
dna
fragment
k
correspond
region
hindiii
dna
fragment
jl
respect
posit
inpati
n
outpati
n
show
increas
preval
antibodi
herp
virus
differ
particularli
evid
cmvigg
preval
hospit
outpati
hiv
neg
patient
antihbc
low
preval
control
markedli
associ
progress
hiv
infect
preval
outpati
inpati
antibodi
pattern
opportunist
viral
infect
may
regard
marker
pathogen
hiv
infect
patient
strong
crossreact
two
serotyp
herp
simplex
viru
hsv
difficult
distinguish
hsvl
antibodi
patient
sera
although
genit
herp
caus
hsvl
case
caus
recurr
genit
herp
serolog
differenti
past
past
hsvl
infect
necessari
identifi
pregnanc
like
complic
recurr
matern
infect
improv
enzymelink
immunosorb
assay
elisa
addit
test
sera
western
blot
abl
specif
identifi
hsvland
serum
sampl
elisa
immobil
micro
titer
plate
nunc
patient
sera
ad
antibodi
detect
biotinstreptavidin
peroxidas
western
blot
electrophoret
separ
use
antigen
blot
polyvinylidenedifluorid
pvdf
membran
pharmacia
incub
test
sera
antibodi
typespecif
glycoprotein
hsv
type
form
sharp
band
visual
applic
biotinlstreptavidin
peroxidas
result
show
elisa
western
blot
correl
serum
sampl
high
antibodi
titer
hsvl
show
fals
posit
reaction
case
optic
densiti
sera
rang
around
cutoff
valu
elisa
sampl
could
easili
identifi
western
blot
serolog
studi
show
prostitut
n
antibodi
hsvl
type
antibodi
could
found
furthermor
femal
patient
gynecolog
treatment
n
antibodi
hsv
type
case
serotyp
show
antibodi
reaction
roughli
preval
hsvl
antibodi
found
patient
dermatolog
depart
eishubing
k
kurowski
k
e
schnewei
inst
f
med
mikrobiologi
u
immunologi
univ
bonn
nonneutr
monoclon
antibodi
mab
direct
glycoprotein
gc
herp
simplex
viru
type
hsvl
neutral
mab
glycoprotein
gb
evalu
abil
protect
mice
genit
hsvinfect
nonneutr
mab
littl
effect
viru
replic
mucou
membran
complet
protect
mice
peripher
skin
lesion
neurolog
ill
death
progress
viru
central
nervou
system
obvious
inhibit
modifi
cours
ganglion
infect
number
ganglia
present
infecti
viru
final
latenc
reduc
although
earli
latenc
induc
addit
effect
nonneutr
mab
neutral
mab
effect
shorten
viral
shed
vagina
convert
prolif
ganglion
infect
latenc
differ
mode
action
monoclon
antibodi
discuss
context
possibl
defens
mechan
humor
immun
viru
prolifer
mucou
membran
ganglia
thymidin
kinas
tk
gene
bovin
herpesviru
bhvl
serv
integr
locu
foreign
dna
viral
genom
express
function
activ
tk
essenti
viral
replic
tk
gene
bhv
locat
convers
tk
neg
cell
tk
phenotyp
marker
rescu
experi
contain
open
read
frame
bp
sequenc
comparison
herpesvir
tkproteinsequ
reveal
certain
part
amino
acid
sequenc
nucleotid
bind
loop
highli
conserv
hybrid
rna
infect
cell
tkdna
show
tkmrna
size
kb
wherea
size
tkmrna
herpesvirus
measur
kb
tk
transcript
unit
character
use
nucleas
open
read
frame
translat
protein
homolog
glycoprotein
h
gh
herp
simplex
viru
type
lie
downstream
open
read
frame
tkgene
conclud
express
bhvlgh
correl
express
thymidin
kinas
preliminari
result
suggest
transcript
gene
initi
one
common
promot
footandmouth
diseas
viru
fmdv
infect
cell
disappear
nuclear
protein
histon
simultan
appear
new
chromatin
associ
protein
term
pi
observ
sequenc
amino
terminu
pi
clearli
show
protein
pi
deriv
histon
proteolyt
cleavag
ntermin
amino
acid
residu
specif
cleav
earli
infect
addit
use
vitro
transcriptiontransl
assay
differ
fmdv
clone
show
histon
pi
transit
fmdv
proteas
depend
proteas
found
respons
process
viral
polyprotein
proteas
fmdv
protein
requir
induc
histon
transit
ii
viral
protein
perform
specif
cleavag
iii
viral
precursor
fusion
protein
necessari
specif
cleavag
report
process
polioviru
precursorpolyprotein
mediat
histon
cleavag
restrict
chromatin
deriv
natur
host
cell
delet
part
histon
correspond
domain
presum
involv
regul
transcript
activ
chromatin
eucaryot
postul
specif
cleavag
mechan
fmdv
util
switch
host
cell
rna
synthesi
report
picornavirus
combin
report
mechan
host
cell
translat
shut
cleavag
capbind
protein
complex
specif
histon
cleavag
could
contribut
almost
complet
breakdown
host
cell
function
infect
tk
hsv
contain
three
region
homolog
highli
conserv
sequenc
nucleotid
bind
enzym
residu
nucleotid
bind
loop
residu
residu
comparison
viral
cellular
tk
protein
sequenc
structur
analysi
led
hypothesi
asp
might
involv
bind
acyclovir
use
therapeut
hsv
infect
site
specif
mutagenesi
replac
asp
asn
led
polypeptid
tk
activ
found
residu
present
cellular
tk
delet
mutant
gene
integr
vaccinia
viru
studi
biochem
properti
result
polypeptid
analyz
import
mutat
sequenc
function
activ
enzym
contrast
human
glioma
cell
line
adenoviru
transform
kidney
cell
line
reveal
replic
organspecif
variant
earli
hour
pt
nevertheless
amount
replic
dna
kidney
variant
clearli
reduc
glioma
cell
replic
dna
detect
later
cn
variant
data
conclud
thatjcv
replic
regul
host
type
specif
also
cell
type
specif
manner
young
human
volunt
vaccin
kill
hepat
vaccin
produc
human
embryo
fibroblast
cell
differ
amount
vaccin
administ
intramuscular
rout
week
first
vaccin
lg
vaccin
volunt
seroconvert
week
second
inject
seroconvers
rate
antihav
determin
quantit
result
show
antihav
titer
time
higher
gamma
globulin
administr
one
year
vaccin
volunt
still
antihav
titer
sera
time
higher
gamma
globulin
administr
human
papillomavirus
hpv
associ
epidermodysplasia
verruciformi
syndrom
ev
repres
group
close
relat
virus
clearli
distinct
hpv
interest
featur
evvirus
high
oncogen
potenti
specif
viru
type
ii
extrem
narrow
host
rang
get
insight
molecular
basi
process
control
viral
express
studi
sequencespecif
dnaprotein
interact
within
genom
regulatori
region
use
nuclear
extract
hela
cell
combin
exonucleas
iiiand
dnase
ifootprint
techniqu
protein
bind
map
construct
prototyp
virus
high
versu
low
oncogen
potenti
sequenc
question
show
complex
array
protein
bind
domain
cover
almost
entir
length
regulatori
region
cluster
promin
bind
site
overlap
sequenc
motif
highli
conserv
element
evvirus
investig
detail
transient
cat
assay
motif
dimer
trimer
found
act
strong
express
activ
analysi
sequenc
bandshift
test
reveal
partial
differ
set
dna
bind
protein
interact
element
hpv
one
protein
least
case
shown
regulatori
factor
api
part
sequenc
vicin
bind
site
display
homolog
enhanc
element
small
dna
virus
gerritzen
jp
kleim
friedrich
inst
med
microbiolog
univ
bonn
semiquantit
detect
hepat
b
viru
hbv
dna
sera
infect
individu
becom
import
mean
modern
serolog
hepat
diagnost
enabl
investig
draw
conclus
infect
prognosi
therapeut
success
molecular
hybrid
use
radioact
e
label
dna
probe
subsequ
autoradiographi
character
high
sensit
specif
altern
digoxigeninlabel
probe
detect
enzym
immunoassay
employ
use
method
pg
hbv
dna
aqueou
solut
detect
high
specif
membran
made
cellulos
nitrat
test
sera
hepat
patient
pg
hbv
dna
detect
nylon
membran
pore
size
e
p
pg
unfortun
specif
remain
disappoint
even
centrifug
digest
proteinas
k
treatment
sera
phenolechloroform
object
assess
risk
laboratori
personnel
result
patient
unknown
hiv
infect
sera
sent
institut
medic
virolog
immunolog
imvi
essen
immunolog
andor
virolog
test
anonym
screen
hiv
antibodi
method
juli
decemb
total
sera
differ
depart
univers
clinic
essen
select
screen
code
basi
hiv
antibodi
test
request
diagnost
purpos
time
sera
patient
found
antihiv
posit
previou
year
disregard
n
sera
reactiv
elisa
enzygnostantihiv
behr
test
second
dupont
third
elisa
pasteur
confirmatori
test
western
blot
wb
dupont
result
sera
patient
suspect
hiv
infect
hiv
antibodi
confirm
wb
tabl
addit
sera
show
less
specif
band
consid
indetermin
sera
unknowingli
infect
patient
sent
often
intern
n
dermatolog
depart
n
wherea
sera
indetermin
hiv
antibodi
result
mostli
origin
patient
receiv
tumor
treatment
n
conclus
preval
unknown
hiv
infect
reflect
higher
rate
gener
assum
possibl
result
select
univers
patient
immunolog
disord
underli
hiv
infect
overal
preval
antihiv
posit
sera
suggest
strict
adher
infect
control
measur
medic
laboratori
bovin
viral
diarrhea
viru
bvdv
member
pestiviru
group
cultur
bovin
cell
non
cytopath
ncp
cytopath
cp
biotyp
distinguish
use
radioimmunoprecipit
monoclon
antibodi
mab
detect
kd
nonstructur
ns
polypeptid
cell
infect
ncpbvdv
cell
infect
cpbvdv
addit
kd
protein
precipit
second
set
mab
direct
kd
minor
glycoprotein
distribut
protein
cell
infect
two
biotyp
analyz
immunofluoresc
analysi
ifa
none
two
protein
detect
surfac
live
infect
cell
ns
protein
homogen
distribut
cytoplasm
cell
infect
biotyp
second
set
mab
display
differ
stain
pattern
cell
infect
biotyp
cell
infect
cpbvdv
homogen
cytoplasm
fluoresc
visibl
cell
infect
ncpbvdv
stain
larg
restrict
perinuclear
zone
give
distinct
stain
mab
possibl
signific
result
cytopathogen
discuss
sera
patient
varieti
inflammatori
rheumat
diseas
autoantibodi
selfantigen
autoantigen
found
one
hypothes
molecular
basi
autoimmun
diseas
discuss
intens
sinc
decad
assum
structureor
sequencerel
epitop
viru
host
protein
might
involv
initi
autoimmun
process
molecular
mimicri
search
crossreact
sequenceident
epitop
cell
viru
protein
start
map
detail
antigen
region
individu
epitop
autoantigen
detail
studi
perform
ulsnrnp
specif
protein
major
target
autoantibodi
system
rheumat
diseas
mix
connect
tissu
diseas
system
lupu
erythematosu
immunoblot
elisa
assay
perform
recombin
fusion
protein
peptid
four
antigen
region
mani
patient
specif
epitop
could
map
one
antigen
region
epitop
amino
acid
long
could
identifi
also
present
matrix
protein
influenza
b
virus
affin
purifi
specif
autoantibodi
reaction
influenza
b
viru
protein
vice
versa
could
experiment
verifi
result
demonstr
first
time
autoantibodi
patient
rheumat
diseas
recogn
epitop
ident
sequenc
highli
preval
pathogen
viru
major
auto
antigen
target
whether
exist
common
epitop
chanc
causual
relat
current
investig
detect
antibodi
cytomegaloviru
hcmv
induc
earli
antigen
immunoblot
contradictori
inform
diagnost
assess
antibodi
earli
antigen
human
cytomegaloviru
hcmv
numer
publish
investig
correl
incid
antibodi
hcmv
earli
protein
state
infect
ninetysix
hcmviggposit
sera
elisa
test
specif
iggantibodi
hcmv
earli
antigen
immunoblot
three
group
examin
renal
transplant
patient
b
aidspati
c
randomli
select
healthi
individu
group
yield
approxim
percentag
posit
immunoblot
sera
belong
group
b
react
stronger
recogn
greater
number
polypeptid
compar
healthi
person
immunoblotposit
sera
react
least
protein
major
immedi
earli
protein
fourteen
hcmvigmposit
sera
elisa
belong
group
b
recogn
earli
antigen
twentytwo
hcmvigmneg
sera
react
well
conclud
acut
hcmv
infect
caus
format
antibodi
earli
antigen
individu
furthermor
antibodi
persist
subclinicallat
infect
bern
viru
bev
isol
hors
prototyp
torovirida
propos
new
famili
positivestrand
rna
virus
bev
virion
consist
peplomerbear
membran
envelop
tubular
nucleocapsid
helic
symmetri
structur
straight
result
tubular
particl
bent
open
toru
confer
shape
kidney
biconcav
disc
virion
nucleocapsid
contain
singl
polyadenyl
rna
molecul
kb
abund
polypeptid
basic
phosphoprotein
nucleic
acid
bind
properti
upon
infect
set
sub
genom
mrna
synthes
leaderindepend
transcript
uniqu
sequenc
mrna
translat
combin
virion
structur
nucleocapsid
protein
size
leaderindepend
transcript
uniqu
virolog
justifi
famili
statu
bev
relat
virus
howev
coronavirus
similar
genom
organ
nest
set
mrna
sequenc
similar
second
orf
polymeras
gene
bev
sinc
latter
suggest
common
ancestri
toroand
corona
virus
togeth
may
consid
third
evolutionari
cluster
positivestrand
rna
virus
addit
alphaand
picornaviru
superfamili
w
ilg
h
mairhof
c
markert
h
wolf
max
v
pettenkoferinst
hygien
med
microbiolog
univ
munich
order
character
viral
nonvir
structur
respons
recognit
ebvinfect
lymphocyt
immun
system
studi
reactiv
ebvspecif
cytotox
cell
toward
autolog
ebvposit
lymphoblastoid
cell
line
lcl
lcl
establish
differ
ebvposit
donor
either
spontan
outgrowth
cell
transform
donor
viru
infect
laboratori
strain
ebv
b
cell
line
use
gener
ebvspecif
cytotox
cell
weekli
stimul
addit
interleukin
cell
clone
limit
dilut
chromium
releas
assay
posit
cell
line
clone
abl
discrimin
two
autolog
lymphoblastoid
cell
line
infect
either
viru
strain
b
strain
respect
experi
use
variou
concentr
effector
cell
show
structur
recogn
differ
cell
clone
express
certain
percentag
cell
lcl
nonvir
compon
differ
express
differ
lcl
also
seem
playa
role
ctlllcl
interact
largescal
product
purif
recombin
gp
lead
nativ
biolog
activ
protein
bound
specif
cd
receptor
antihb
respons
hb
vaccin
recipi
within
ongo
immun
cours
studi
vitro
antigen
specif
antibodi
product
prolif
respons
well
express
secret
detect
aim
studi
analyz
effect
variou
cell
stimuli
mitogen
lymphokin
antibodi
cell
surfac
antigen
antigenspecif
immun
respons
vitro
pwm
driven
enhanc
hb
specif
antibodi
product
shown
time
depend
contrast
iii
incub
led
signific
increas
antihb
antibodi
synthesi
low
dose
led
signific
increas
hb
induc
express
moreov
induc
secret
enhanc
hb
antigen
receptor
express
hb
vaccin
nonrespond
pbmc
reduc
compar
respond
group
receptor
express
respond
pbmc
influenc
antigen
well
iii
wherea
modul
seen
nonrespond
pbmc
capac
nonrespond
cell
respond
hb
antigen
reduc
wherea
capac
cell
respond
iii
markedli
enhanc
summari
data
show
hb
specif
immun
respons
vitro
influenc
lymphokin
sera
women
n
sera
men
n
found
contain
antibodi
direct
gene
product
hpv
type
mention
femal
male
sera
exhibit
antibodi
direct
andor
gene
product
hand
individu
femal
serum
antibodi
direct
el
could
found
anoth
one
harbour
antibodi
direct
antibodi
igg
type
order
specifi
whether
antibodi
papillomavirus
associ
sexual
activ
use
sera
femal
individu
age
year
old
test
also
sera
individu
subsequ
taken
time
interv
year
could
shown
antibodi
present
sera
whole
period
time
howev
also
increas
frequenc
antibodi
direct
hpv
grow
age
women
observ
data
indic
besid
distribut
human
papillomavirus
sexual
intercours
rout
papillomaviru
infect
may
exist
instanc
perinat
infect
experi
reveal
differ
salt
stabil
ph
depend
gd
gb
gc
respect
bind
abil
thu
bind
gd
could
disrupt
mm
nacl
ph
optimum
wherea
bind
gc
gb
show
ph
optimum
near
stabl
even
salt
concentr
nacl
result
given
provid
direct
evid
function
role
gc
gb
gd
bind
cell
surfac
h
demonstr
electron
microscopi
mechan
effect
due
irrevers
bind
metal
ion
viral
membran
presum
mercaptan
group
viral
glycoprotein
adsorpt
zinc
inactiv
viru
reduc
extent
wherea
heavi
impact
presum
viru
penetr
small
concentr
rang
zn
cultur
medium
inhibitori
viru
replic
infect
cell
without
seriou
toxic
cell
therefor
mechan
vivo
efficaci
zinc
prepar
hsv
lesion
mucosa
mainli
base
upon
inactiv
free
viru
partli
due
virustasi
inhibit
hsv
adsorpt
experi
done
either
synthet
peptid
cell
transfect
gene
encod
ebv
latent
membran
protein
bnlfi
suggest
protein
target
ebv
specif
cytotox
tcell
ctl
experi
close
resembl
natur
situat
want
expand
topic
establish
system
better
reflect
vivo
condit
construct
two
recombin
vaccinia
virus
one
carri
complet
bnlf
lma
read
frame
encod
truncat
form
bnlf
ima
contain
third
exon
found
ebv
infect
burkitt
lymphoma
addit
downregul
full
length
protein
continu
code
sequenc
complet
gene
necessari
express
foreign
protein
recombin
vaccinia
clone
genom
fragment
synthet
oligonucleotid
infect
sever
cell
type
includ
freshli
isol
pbl
express
form
lmp
clearli
demonstr
immunoblot
immunofluoresc
ebv
specif
cytotox
tiymphocyt
ctl
gener
repeat
stimul
autolog
ebv
infect
lymphoblastoid
cell
presenc
react
autolog
pha
stimul
blast
infect
two
vaccinia
virus
wild
type
viru
control
ctl
two
person
recogn
full
length
bnlfi
protein
shorten
protein
wherea
ctl
two
person
recogn
two
bnlfi
protein
experi
conclud
nterminu
bnlfi
protein
contain
determin
recogn
ebvspecif
ctl
addit
protein
target
ebvspecif
ctl
express
epsteinbarr
viru
regul
gene
bmlfi
regul
promoterenhanc
complex
locat
upstream
short
orf
bslfi
transcrib
splice
unit
region
tata
box
contain
consensu
sequenc
bind
transcript
factor
eg
nfl
apl
analyz
activ
control
region
differ
cell
system
use
appropri
report
assay
chloramphenicol
acetyltransferas
hepat
b
viru
surfac
antigen
report
gene
bp
aluilbsteii
fragment
includ
tata
box
shown
suffici
promot
transcript
raji
cell
induc
lytic
ebv
express
differ
procedur
respons
phorbolest
shown
ebv
neg
cell
upstream
region
bmlfi
promot
bp
bsteiiissti
fragment
identifi
regulatori
segment
transfect
assay
show
posit
neg
effect
depend
presenc
state
ebv
ebv
neg
cell
hela
upstream
element
clearli
respond
ebv
transactiv
brlfl
specif
transactiv
distal
control
region
brlfi
express
vector
pksvr
kindli
provid
sergeant
lyon
downregul
latent
infect
cell
raji
ebv
produc
cell
transact
brlfi
detect
follow
insert
heterolog
express
system
upstream
control
region
enhanc
transcript
earli
promot
independ
orient
previous
shown
mutant
prv
express
nonessenti
glycoprotein
gill
adsorb
less
readili
cell
wildtyp
viru
show
first
interact
prv
target
cell
occur
via
bind
viru
heparinlik
compon
cell
surfac
viral
protein
mediat
bind
glycoprotein
gill
conclus
base
follow
find
heparin
inhibit
adsorpt
wildtyp
prv
effect
measur
plaqu
format
well
attach
radioact
label
viru
cell
howev
affect
adsorpt
gillmut
slightli
wildtyp
prv
bind
well
matrixbound
heparin
bind
giiimut
dramat
reduc
pretreat
cell
heparinas
reduc
plaqu
format
adsorpt
wildtyp
pri
affect
gill
mutant
pri
membran
protein
glycoprotein
glii
bind
abundantli
specif
heparin
sepharos
bead
result
indic
bind
pri
via
glycoprotein
glii
heparinlik
cellular
compon
promot
effici
adsorpt
absenc
glii
heparinlik
cellular
receptor
viru
adsorb
altern
less
effici
mode
e
metzler
r
wyler
inst
virolog
univ
ziirich
switzerland
bovin
herpesviru
caus
two
well
establish
entiti
name
infecti
bovin
rhinotrach
ibr
infecti
pustular
vulvovagin
ipv
enceph
third
entiti
less
well
understood
wherea
ibr
usual
follow
horizont
viru
spread
aerosol
ipv
acquir
vener
contact
remain
controversi
condit
associ
distinct
virus
restrict
endonucleas
analysi
viral
dna
evalu
viral
protein
follow
separ
sdspolyacrylamid
gel
may
use
distinguish
protein
european
field
isol
recov
distinct
diseas
episod
within
time
period
compar
protein
establish
laboratori
strain
field
isol
classifi
none
regularli
recov
cattl
genit
afflict
howev
strain
origin
anim
ibr
other
abort
fetus
well
first
recognit
among
field
isol
coincid
sequenti
wave
sever
ibr
outbreak
throughout
europ
result
obtain
laboratori
strain
indic
obvious
limit
pathogen
potenti
must
exist
earlier
time
togeth
publish
data
result
suggest
recognit
strain
necessarili
reflect
specif
pathogen
potenti
distinct
organ
tropism
nevertheless
sever
ibr
incid
clearli
associ
virul
demonstr
late
gene
product
certain
papillomaviru
type
exhibit
dnabind
activ
hepat
b
viru
core
protein
also
exampl
interact
viral
capsid
protein
nucleic
acid
case
dna
bind
mediat
carboxi
termin
locat
cluster
basic
aa
residu
similarli
gene
product
contain
also
group
basic
amino
acid
carboxi
terminu
examin
whether
region
fact
dna
bind
site
express
differ
part
gene
e
coli
gal
fusion
protein
vector
system
use
allow
cleavag
viral
protein
gal
collagenas
digest
differ
express
product
whole
protein
carboxi
termin
part
bound
dna
specifi
dna
bind
site
code
sequenc
last
amino
acid
fuse
gal
measur
dna
bind
activ
could
transfer
gal
formerli
exhibit
properti
collagenas
digest
use
specif
polyclon
antibodi
ensur
dna
bind
genuin
attribut
gene
product
latter
enzym
differenti
cleav
preferenti
sialic
acid
attach
galactos
via
natreat
cell
resialyl
use
specif
sialyltransferas
cmpsialic
acid
transferas
attach
sialic
acid
gal
abl
restor
receptor
bfdv
accordingli
cultur
chicken
embryo
cell
resist
bfdv
infect
follow
destruct
receptor
na
treatment
detect
cytomegaloviru
antigen
bodi
fluid
becom
increasingli
importantfor
purpos
studi
blood
urin
specimen
immunosuppress
patient
renal
transplant
recipi
heart
liver
transplant
recipi
patient
aid
test
hcmv
indic
cell
cultur
foreskin
fibroblast
inocul
urin
leucocyt
respect
resp
day
inocul
subject
immunoperoxidas
stain
ip
use
monoclon
antibodi
dupont
frg
direct
hcmv
earli
antigen
control
cell
cultur
inocul
leucocyt
examin
hcmvspecif
cytopath
effect
cpe
day
addit
leucocyt
patient
subject
insituhybrid
biotinlabel
hcmv
ad
eco
ri
jfragment
probe
serum
sampl
test
presenc
hcmvspecif
antibodi
ig
class
g
elisa
behr
frg
hcmv
detect
blood
urin
sampl
patient
blood
sampl
posit
ip
cpe
ip
cpe
hybrid
assay
neg
virolog
posit
case
titr
hcmvspecif
antibodi
amount
reciproc
titr
igg
case
signific
rise
titr
case
igm
case
iga
case
result
indic
laboratori
diagnosi
activ
hcmv
infect
detect
hcmv
earli
antigen
urin
regard
practic
rapid
superior
test
viremia
consid
help
extens
serolog
test
moreov
urin
sampl
easili
obtain
detect
hcmv
earli
antigen
urin
especi
appropri
control
cours
activ
hcmv
infect
kaiolaf
netzer
axel
rethwilm
volker
ter
meulen
inst
f
virologi
u
immunbiologi
univ
wiirzburg
human
spumaretroviru
hsrv
distinct
member
foami
viru
subfamili
retrovirida
genom
kilo
base
sequenc
compris
typic
retrovir
gene
gag
pol
env
least
three
open
read
frame
possibl
code
regulatori
protein
thu
far
much
known
gene
product
hsrv
mean
radioimmunoprecipit
identifi
partli
character
major
immunogen
antigen
hsrv
radiolabel
viral
protein
precipit
hsrvposit
sera
hsrvneg
control
sera
rang
kilodalton
kda
appar
molecular
weight
label
methionin
presenc
tunicamycin
led
identif
three
viral
glycoprotein
kda
appar
molecular
weight
respect
glycoprotein
like
repres
env
gene
product
phosphoryl
protein
kda
may
relat
gag
gene
hsrv
result
studi
show
radioimmunoprecipi
provid
power
diagnost
research
tool
identifi
hsrvposit
sera
thoma
nowak
gerd
wengler
inst
f
virologi
univ
giefen
present
address
behringwerk
ag
marburg
primari
structur
nonstructur
protein
wnv
determin
nonstructur
protein
isol
nuclear
membran
fraction
wnv
infect
bhk
cell
aminotermin
sequenc
data
purifi
protein
determin
togeth
publish
amino
acid
sequenc
nonstructur
code
genom
region
castl
et
ai
virolog
obtain
sequenc
nonstructur
protein
kd
kd
kd
kd
kd
kd
gene
order
size
viru
code
protein
process
nonstructur
protein
appear
ident
flavivirus
well
accept
function
impair
kill
infect
cell
hypersensit
autoimmun
contribut
symptom
patholog
viral
diseas
discuss
evid
addit
mechan
defin
uncontrol
activ
host
effector
function
focus
viral
antigen
autotox
evid
follow
situat
certain
paramyxovirus
influenza
virus
capabl
activ
gener
reactiv
oxygen
speci
phagocyt
absenc
antivir
antibodi
reaction
trigger
bind
viral
surfac
glycoprotein
plasma
membran
phagocyt
inject
blood
stream
virus
exert
toxic
effect
independ
viral
replic
ii
liver
damag
observ
model
murin
influenza
despit
appar
lack
viral
replic
organ
effect
may
mediat
cytokin
iii
canin
distemp
demyelin
occur
despit
appar
lack
viral
replic
oligodendrocyt
cell
form
myelin
degener
uninfect
oligodendrocyt
also
observ
dissoci
brain
cell
cultur
measur
luminoldepend
chemiluminesc
antivir
antibodi
stimul
gener
reactiv
oxygen
microgli
cell
link
fe
receptor
viral
antigen
express
surfac
infect
cell
e
g
astrocyt
cell
cultur
oligodendrocyt
readili
destroy
reactiv
oxygen
speci
gener
xanthin
xanthin
oxidas
sera
januari
august
analyz
retrospect
hepat
hepat
b
marker
evalu
age
distribut
season
distribut
acut
hepat
viru
infect
group
patient
german
foreign
name
determin
case
acut
hepat
foreign
popul
occur
septemb
decemb
patient
year
age
german
popul
season
peak
could
found
howev
one
peak
anoth
year
age
see
season
peak
acut
infect
hepat
b
viru
age
preferenti
affect
infect
occur
earlier
foreign
popul
german
peopl
group
case
acut
infect
hepat
hepat
b
virus
rare
found
foreign
peopl
german
marker
hepat
hepat
b
glycoprotein
complex
gil
belong
essenti
membran
protein
pseudorabi
viru
prv
therefor
mutat
analys
viral
gil
requir
growth
respect
mutant
complement
gilexpress
cell
line
cell
line
capabl
suppli
gil
tran
isol
cotransfect
genom
prydna
fragment
encompass
complet
viral
gilexpress
unit
plasmid
confer
resist
antibiot
viral
express
unit
usual
silent
transactiv
superinfect
herp
simplex
viru
hsvl
transient
express
pri
immedi
earli
protein
suffici
induc
transactiv
immunofluoresc
radioimmunoprecipit
use
gilspecif
monoclon
antibodi
express
authent
gil
could
demonstr
attempt
isol
constitut
gilexpress
cell
line
fail
presum
due
toxic
express
glycoprotein
result
regard
process
gil
without
context
pryinfect
present
furthermor
avail
cell
line
enabl
us
specif
mutat
gilgen
pri
genom
character
result
mutant
biolog
cellular
humor
immun
reaction
import
pathogenesi
viral
infect
anim
model
mv
enceph
lewi
rat
develop
subacut
cn
diseas
process
presenc
low
level
neutral
antivir
antibodi
contribut
mvspecif
cellular
immun
diseas
yet
unknown
therefor
vitro
reactiv
polyclonallymphocyt
cultur
mv
structur
compon
determin
addit
possibl
replac
purifi
viral
antigen
bacteri
express
fusion
protein
studi
cell
prime
immun
antigen
emulsifi
freund
complet
adjuv
cell
prepar
regionallymphnod
taken
cultur
day
later
lymphoprolifer
measur
incorpor
tritiat
thymidin
presenc
specif
irrelev
antigen
panel
antigenspecif
cell
line
polyclon
cell
popul
except
prime
recombin
haemagglutinin
pbdh
specif
prolifer
obtain
either
whole
inactiv
mv
immun
antigen
use
restimul
nucleocapsid
n
matrix
specif
cell
line
recogn
equal
well
pbdn
virion
purifi
n
nv
pbdm
mv
respect
substitut
pbdh
hv
found
observ
indic
induct
differenti
cell
depend
immun
respons
procaryot
express
h
compar
h
glycoprotein
purifi
virion
k
rittert
b
nellent
h
eiffertl
h
kratzin
r
thomssen
cours
acut
epsteinbarr
viru
ebv
infect
igm
antibodi
alway
occur
two
cellular
antigen
character
protein
molecular
weight
kd
kd
respect
purifi
identifi
monom
human
triosephosph
isomeras
htpi
far
unknown
protein
possess
high
homolog
triosephosph
isomeras
rabbit
rtpi
two
autoantibodi
produc
igm
class
antibodi
switch
igg
presum
antibodi
monoclon
percent
patient
percent
case
acut
hepat
viru
hav
infect
antihtpiirtpi
antibodi
found
acut
ebv
infect
well
acut
ha
v
infect
may
complic
hemolysi
differ
extent
igm
antihtpiirtpi
antibodi
purifi
affin
chromatographi
caus
increas
releas
human
erythrocyt
rh
negatic
group
contribut
autoantibodi
hemolysi
acut
viral
infect
like
investig
first
attempt
tri
express
hbv
pre
epitop
aminotermin
fusion
hbc
attempt
result
detect
express
due
instabl
toxic
insert
oligonucleotid
code
two
overlap
pre
epitop
dprvrglyfpa
immunol
immunol
site
duck
hepat
viru
core
antigen
insert
amino
acid
found
compar
mammalian
hepat
virus
predict
surfac
particl
insert
result
express
stabl
fusion
protein
antigen
westernblot
chromatograph
behaviour
hbdpre
chimaera
sepharos
similar
authent
recombin
core
particl
suggest
assembl
particl
rabbit
antipr
antiserum
kindli
provid
r
neurath
recogn
hbdpre
particl
nondenatur
elisa
type
assay
monoclon
antibodi
second
epitop
show
part
insert
sequenc
access
particl
sinc
express
hbc
particl
carri
epitop
eeoli
immunolog
properti
induct
tcell
bcell
respons
purifi
particl
investig
w
character
enzymelink
immunosorb
assay
ag
identif
type
hsv
discuss
differenti
hsv
evalu
laboratori
hsv
strain
shown
type
indic
valid
broad
dilut
rang
essenti
sampl
low
high
antigen
content
preliminari
clinic
studi
n
specimen
direct
test
reveal
identif
sensit
type
sensit
overal
specif
confirmatori
test
agreement
identif
type
obtain
basi
result
conclud
ag
suitabl
altern
cell
cultur
method
sinc
overcom
failur
viru
isol
due
possibl
inactiv
result
improp
transport
andor
storag
specimen
comparison
convent
hsv
detect
type
test
system
ag
offer
follow
advantag
eas
perform
within
less
expens
subject
read
test
result
use
elisa
photomet
computercontrol
autom
use
microtitr
plate
possibl
sera
person
age
test
parallel
biotin
avidin
western
blot
bawb
biotin
avidin
enzymelink
immunosorb
assay
baelisa
complement
fixat
techniqu
cft
antigen
use
test
studi
prepar
human
adenoviru
type
specif
iggantibodi
direct
two
immunoblot
groupspecif
major
adenovir
polypeptid
hexon
epitop
aantigen
penton
base
antigen
found
case
antibodi
found
baelisa
cft
preval
iggand
igaantibodi
human
adenoviru
studi
baelisa
serum
sampl
obtain
differ
agegroup
frankfurtmain
west
germani
lowest
iggantibodi
preval
measur
sixto
agegroup
increas
sixto
sevenyear
agegroup
lot
adenoviru
posit
sera
specif
igaantibodi
measur
oneto
two
twoto
three
year
agegroup
second
peak
igaantibodi
preval
appear
sixto
sevenyear
sevento
eightyear
agegroup
highest
preval
antiadenoviru
igg
seen
revers
transcriptas
necessari
viral
replic
therefor
attract
candid
antivir
therapi
detail
function
structur
analysi
like
e
g
cristallograph
studi
neutron
solut
scatter
predisposit
develop
new
inhibitor
affect
revers
transcriptas
activ
purpos
construct
plasmid
allow
high
level
express
activ
revers
transcriptas
introduct
e
coli
partial
adopt
e
coli
codon
usag
ad
origin
aminoand
carboxi
termin
sequenc
synthet
oligonucleotid
abl
produc
authent
enzym
e
coli
consider
amount
total
e
coli
protein
stabl
form
shown
coomassi
stain
western
blot
analysi
mutant
addit
amino
acid
fuse
aminotermin
sequenc
show
lower
express
increas
access
bacteri
proteas
activ
authent
amino
termin
alter
enzym
compar
standard
method
activ
gel
procedur
enzym
activ
could
detect
kd
werea
activ
could
detect
kd
recombin
produc
enzym
use
purif
crystallograph
studi
genom
hog
cholera
viru
hcv
consist
rna
kb
length
rna
contain
one
larg
open
read
frame
l
probabl
translat
polyprotein
process
proteolyt
metabol
label
radioimmunoprecipit
polyspecif
antiserum
led
identif
four
differ
glycoprotein
hcv
infect
cell
inhibit
nlink
glycosyl
treatment
infect
cell
tunicamycin
result
distinct
chang
migrat
behavior
protein
sdspage
variou
cdna
fragment
locat
region
code
hcv
encod
glycoprotein
express
fusion
protein
bacteria
purifi
fusion
protein
use
prepar
antibodi
specif
respect
hcv
glycoprotein
serolog
reagent
use
radioimmunoprecipit
assay
western
blot
follow
conclus
drawn
repres
differ
process
form
singl
protein
patient
epidermodysplasia
verruciformi
ev
induc
lesion
higher
risk
malign
convers
evid
viru
occur
also
normal
popul
propag
tissu
cultur
capsid
antigen
readili
avail
seroepidemiolog
studi
therefor
express
major
structur
protein
fragment
thereof
gal
fusion
protein
bacteria
express
vector
pro
encod
fxacleavag
site
allow
separ
viral
bacteri
moieti
proteolyt
digest
purifi
viral
antigen
use
test
sera
western
blot
analysi
sera
reveal
antibodi
dilut
case
titer
exceed
antibodi
preval
similar
age
group
western
blot
fragment
show
humor
immunorespons
differ
person
alway
direct
epitop
molecular
basi
lack
hbeag
virem
sera
acut
chronic
infect
patient
clear
studi
investig
whether
group
patient
infect
hbv
variant
synthes
hbeag
viral
dna
isol
sera
hbeag
neg
chronic
carrier
amplifi
per
sequenc
directli
clone
patient
sera
hbv
variant
found
common
stop
codon
precor
region
sinc
precor
protein
precursor
synthesi
classic
hbeag
one
conclud
precor
mutat
hbv
variant
respons
lack
hbeag
serum
patient
result
also
implic
express
hbeag
essenti
viabil
hbv
least
immunosuppress
condit
precor
mutat
seem
drastic
effect
viral
replic
sinc
high
hbvdna
titer
observ
serum
one
patient
liver
transplant
whether
lack
hbeag
express
also
respons
frequent
sever
progredi
cours
infect
lack
respons
interferon
therapi
current
investig
test
specif
precor
variant
infect
anim
model
inst
virolog
univ
giessen
highli
purifi
nucleoprotein
np
prepar
influenza
viru
infect
cell
yield
addit
commonli
known
kd
protein
kd
compon
could
detect
viru
particl
among
seri
npspecif
monoclon
antibodi
react
protein
other
bound
kd
protein
among
type
npspecif
monoclon
antibodi
limit
number
bound
surfac
murin
cell
infect
type
viru
anoth
categori
antibodi
bound
cell
infect
given
subtyp
fail
react
surfac
cell
infect
differ
subtyp
result
indic
restrict
antigen
domain
nativ
np
perhap
np
fragment
expos
surfac
infect
murin
cell
addit
protect
capac
cellassoci
np
determin
immun
mice
purifi
np
prepar
parallel
order
determin
immunogen
potenc
newli
synthes
np
mice
immun
vaccinia
viru
recombin
contain
gene
np
prior
challeng
infecti
viru
although
immun
mice
produc
monospecif
antibodi
cytotox
cell
respons
employ
form
np
protect
influenza
viru
infect
segment
rna
nephropathia
epidemica
viru
nev
strain
hiillnii
isol
molecular
clone
correspond
cdna
therna
nucleotid
long
termini
complementari
base
viral
messengersens
rna
contain
one
major
open
read
frame
orf
code
capac
amino
acid
encod
kda
polypeptid
compar
hantaan
segment
cdna
sequenc
nucleotid
homolog
homolog
amino
acid
level
mani
amino
acid
differ
conserv
exchang
ctermini
nev
hantaan
nucleocapsid
protein
nearli
ident
hydrophil
profil
similar
potenti
kinas
depend
phosphoryl
site
conserv
contrast
follow
differ
signific
calcul
isoelectr
point
nev
hantaan
nucleocapsid
protein
respect
promin
antigen
determin
predict
hydrophil
profil
locat
close
cterminu
nev
close
nterminu
hantaan
viru
nucleocapsid
polypeptid
bmft
project
footandmouth
dieseas
virusinfect
cell
suffer
cytopath
effect
one
caus
agent
viru
proteas
shown
transient
express
respect
cdna
babi
hamster
kidney
cell
contrast
ednaencod
viru
protein
detect
indirect
immunofluoresc
howev
detect
de
novo
synthes
protein
hour
transfect
radioimmunoprecipit
enzym
indistinguish
size
found
virusinfect
cell
indic
similar
autocatalyt
releas
fuse
protein
transcript
proteas
edna
fragment
inhibit
well
cotransfect
fragment
encod
proteas
analys
northern
blot
hybrid
shut
transcript
one
cytopath
effect
observ
infect
cell
correl
thu
product
activ
proteas
inhibitori
molecular
mechan
may
involv
truncat
nuclear
protein
histon
nterminu
found
western
blot
protein
found
similarli
truncat
virusinfect
cell
virusproteinspecif
antigen
immunogen
tissu
cultur
rabi
vaccin
thraenhart
marcu
k
ramakrishnan
inst
f
med
virologi
u
immunologi
univ
essen
preand
postexposur
treatment
inactiv
rabi
vaccin
prevent
rabi
viru
infect
without
complic
contrast
vaccin
nervou
tissu
origin
consider
divers
concern
viru
strain
pm
fluri
lep
era
cell
strain
chick
fibroblast
bhk
concentr
procedur
ultrafiltr
ultracentrifug
exist
vaccin
differ
produc
influenc
variou
criteria
antigen
immunogen
test
vitro
experi
use
monoand
polyclon
antibodi
rv
protein
antigenelisa
western
blot
immuneelectronmicroscopi
unfraction
fraction
vaccin
rate
zonal
ultracentrifug
immunogen
test
vivo
protect
induct
pi
mice
result
correl
virusspecif
antigen
vpsag
tissu
cultur
supernat
vp
immunglobulinspecif
function
antibodi
ab
interferon
ifn
induct
test
human
vaccine
rv
glycoprotein
gp
nucleocapsid
np
concentr
vaccin
correl
pi
mice
gp
np
ratio
tissu
cultur
vaccin
contrast
brain
vaccin
harvest
gp
np
tc
depend
mainli
cell
strain
virionassoci
solubl
gp
ratio
productionspecif
concentr
virion
tc
vaccin
contain
gp
np
l
induc
vaccine
earli
high
long
last
vp
igg
specif
abrespons
antigp
np
induc
earli
day
ifninduct
correl
appli
dosi
nonrespond
observ
vaccine
protect
level
neutral
ab
day
onward
still
year
frequenc
specif
antibodi
pgene
encod
protein
human
hepat
b
viru
test
sera
acut
chronic
infect
patient
without
hepatocellular
carcinoma
hcc
antibodi
detect
immunoprecipit
gel
assay
perform
radioact
label
polypeptid
produc
vitro
translat
rna
differ
pgene
region
thu
five
antigen
region
identifi
antip
antibodi
posit
sera
react
carboxi
termin
ppolypeptid
subset
polypeptid
aminotermin
middl
region
none
react
pprotein
deriv
sequenc
variabl
region
antip
antibodi
detect
high
frequenc
sera
acut
chronic
infect
patient
without
hcc
less
often
hcc
patient
antip
antibodi
appear
earli
infect
declin
prior
hbsagantihb
seroconvers
data
indirectli
demonstr
express
hbv
pgene
sequenc
high
immunogen
pprotein
vivo
moreov
establish
antip
antibodi
frequent
serolog
marker
infect
identifi
carboxi
termin
region
pprotein
immunodomin
human
polyoma
viru
jc
produc
brain
tumor
hamster
tumor
jcv
tantigen
major
product
earli
gene
gener
express
protein
play
central
role
regul
polyomaviru
replic
sinc
tissu
cultur
major
sourc
tantigen
limit
human
primari
fetal
glial
cell
character
jcv
tantigen
hamster
cell
line
hjc
deriv
jcv
induc
medulloblastoma
southern
blot
analysi
reveal
presenc
jcv
dna
hjc
cell
physic
state
predominantli
integr
transcript
earli
gene
demonstr
presenc
jcv
specif
mrna
northern
blot
nuclear
localis
tantigen
could
establish
immunohistochem
stain
immunoprecipit
crossreact
monoclon
antibodi
pab
molecular
weight
kd
determin
furthermor
western
blot
analysi
could
assum
high
molecular
form
jcv
tantigen
present
hamster
cell
line
taken
togeth
data
demonstr
molecular
weight
nuclear
local
expect
transform
cell
line
therefor
jcv
tantigen
hjc
cell
shall
use
character
dna
bind
capac
origin
region
jc
viru
dna
current
laboratori
diagnosi
coxsackiebviru
cbv
infect
mainli
base
viru
isol
support
detect
rise
high
virusspecif
neutral
antibodi
titer
sinc
high
titr
also
found
appar
healthi
peopleprob
origin
subclin
infect
persist
year
cbvigm
detect
may
reliabl
criteria
serolog
diagnosi
attempt
identifi
antibodi
routin
context
use
convent
techniqu
nt
immunodiffus
solid
phase
immunoassay
eia
ria
revers
elisa
immunoblot
fail
despit
high
sensit
specif
due
high
cost
technic
disadvantag
present
studi
develop
modifi
western
blot
techniqu
modiwestern
blot
enabl
rapid
reliabl
identif
cbvigm
antibodi
assay
antigen
electrophoret
separ
use
integr
electrophoresi
system
phastsystemunit
transfer
solid
matrix
diffus
blot
subsequ
immunodetect
perform
use
biotinavidin
amplif
monoclon
antibodi
apprais
effici
method
human
serum
sampl
analys
virusspecif
antibodi
igm
iga
igg
subclass
coxsackiebvirus
group
specif
igm
respons
could
found
igm
seroposit
case
typepredomin
igm
antibodi
detect
case
case
case
moreov
igglga
assay
patient
seroposit
igg
igm
reveal
case
iga
antibodi
support
evid
acut
cbvinfect
